BRIACELL THERAP (BCTX)
(Delayed Data from NSDQ)
$0.81 USD
-0.43 (-34.68%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $0.84 +0.03 (3.70%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/23/24 |
---|---|
Current Quarter | -0.52 |
EPS Last Quarter | 0.11 |
Last EPS Surprise | 120.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.80 |
Next Year | -0.26 |
EPS (TTM) | -1.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (7/2024) |
Next Year (7/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (7/2024) |
Next Year (7/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.52 | NA | -0.80 | -0.26 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | -0.52 | NA | -0.80 | -0.26 |
High Estimate | -0.52 | NA | -0.80 | -0.26 |
Low Estimate | -0.52 | NA | -0.80 | -0.26 |
Year ago EPS | -0.15 | -0.50 | -1.30 | -0.80 |
Year over Year Growth Est. | -246.67% | NA | 38.46% | 67.50% |
Agreement - Estimate Revisions
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (7/2024) |
Next Year (7/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 1 | 1 |
Up Last 60 Days | 0 | NA | 1 | 1 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 1 | NA | 0 | 0 |
Down Last 60 Days | 1 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (7/2024) |
Next Year (7/2025) |
|
---|---|---|---|---|
Current | -0.52 | NA | -0.80 | -0.26 |
7 Days Ago | -0.52 | NA | -0.80 | -0.26 |
30 Days Ago | -0.46 | NA | -1.39 | -1.00 |
60 Days Ago | -0.46 | NA | -1.39 | -1.00 |
90 Days Ago | -0.46 | NA | -1.39 | -1.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (7/2024) |
Next Year (7/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.52 | NA | -0.80 | -0.26 |
Zacks Consensus Estimate | -0.52 | NA | -0.80 | -0.26 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.11 | -0.71 | -0.50 | -0.15 | NA |
Estimate | -0.55 | -0.20 | -0.18 | -0.40 | NA |
Difference | 0.66 | -0.51 | -0.32 | 0.25 | 0.02 |
Surprise | 120.00% | -255.00% | -177.78% | 62.50% | -62.57% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more